Company intelligence / Profile preview
Conduit Pharmaceuticals Inc.
- Ownership
- Public · CDT
- Employees
- ~6
- Development stage
- Phase 2
Overview
Conduit has completed Phase I trials for AZD1656 in type 2 diabetes, renal transplant, Hashimoto's thyroiditis, uveitis, and preterm labor. AZD5904 has completed Phase I trials for idiopathic male infertility. The company is currently designing a Phase IIa clinical trial for AZD1656 targeting systemic lupus erythematosus with nephritis and ANCA-associated vasculitis. Preclinical studies for AZD5658 in lupus are expected to yield results in Q2 2025[8].
- Therapeutic areas
- Men's HealthOphthalmologyImmunologyEndocrinology
- Modalities
- Small moleculesOral solid-dosage forms
- Industry
- Biotech
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →Partnerships
Financials
- Market cap
- $291.6K
- Total revenue
- $750.2M
- Enterprise value
- $970.9M
Beyond the preview
Go deeper on Conduit Pharmaceuticals Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Conduit Pharmaceuticals Inc..